<DOC>
	<DOCNO>NCT00296348</DOCNO>
	<brief_summary>The primary objective study investigate impact early corticosteroid withdrawal paediatric renal transplant patient growth express change height standard deviation score ( SDS ) baseline end study primary endpoint . The expected advantage reduce growth suppression , low incidence arterial hypertension post transplant diabetes mellitus ( PTDM ) improve lipid metabolism , express low serum lipid value .</brief_summary>
	<brief_title>Comparing Efficacy Safety Steroid Withdrawal With Tacrolimus MMF With Induction Children After Kidney Transplantation</brief_title>
	<detailed_description>Comparing efficacy &amp; safety steroid withdrawal tacrolimus , mycophenolate mofetil ( MMF ) induction child kidney transplantation .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Daclizumab</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Male female patient young 18 young 2 year age Skeletal age boys &lt; = 17 , girl &lt; = 15 year Patient end stage kidney disease Female patient childbearing potential must negative serum pregnancy test prior enrolment must agree practice effective birth control study 6 week thereafter . The patient , case patient minor , patient 's parent ( ) legal representative , fully inform give write informed consent Patient recently measure panel reactive antibody ( PRA ) grade &gt; = 50 % Patient allergic intolerant study medication Patient and/or donor know HIV positive . Patient significant liver disease Patient malignancy history malignancy Patient previously receive receive organ transplant kidney . Patient previously enrol study . Patient relapse nondiarrhoeal form haemolytic uraemic syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Tacrolimus</keyword>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Child</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Immunosuppression</keyword>
</DOC>